Christina Morrison - Nov 17, 2022 Form 4 Insider Report for INVIVO THERAPEUTICS HOLDINGS CORP. (NVIV)

Role
Director
Signature
/s/ Heather Hamel, Attorney-in-fact
Stock symbol
NVIV
Transactions as of
Nov 17, 2022
Transactions value $
$0
Form type
4
Date filed
11/21/2022, 04:00 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVIV Stock Option (right to buy) Award $0 +4.2K $0.00 4.2K Nov 17, 2022 Common Stock 4.2K $2.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on November 17, 2022. 100% of the shares shall vest on November 17, 2023.